Signet Financial Management LLC Has $2.76 Million Stock Holdings in The Cigna Group (NYSE:CI)

Signet Financial Management LLC raised its holdings in The Cigna Group (NYSE:CI) by 0.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,607 shares of the health services provider’s stock after acquiring an additional 39 shares during the period. Signet Financial Management LLC’s holdings in The Cigna Group were worth $2,763,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of CI. Seizert Capital Partners LLC increased its stake in The Cigna Group by 195.8% in the 4th quarter. Seizert Capital Partners LLC now owns 32,150 shares of the health services provider’s stock valued at $9,627,000 after buying an additional 21,280 shares during the last quarter. Roman Butler Fullerton & Co. raised its stake in shares of The Cigna Group by 61.4% during the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock worth $2,772,000 after purchasing an additional 3,539 shares in the last quarter. TFO Wealth Partners LLC boosted its holdings in shares of The Cigna Group by 98,980.0% in the 4th quarter. TFO Wealth Partners LLC now owns 4,954 shares of the health services provider’s stock valued at $1,497,000 after buying an additional 4,949 shares during the last quarter. Ellsworth Advisors LLC acquired a new position in The Cigna Group during the fourth quarter worth $4,377,000. Finally, Sapient Capital LLC bought a new stake in The Cigna Group during the fourth quarter worth $2,811,000. 86.99% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CI shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research note on Wednesday, June 12th. Baird R W upgraded The Cigna Group to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird initiated coverage on shares of The Cigna Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $388.00 price objective for the company. Barclays initiated coverage on shares of The Cigna Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $393.00 target price for the company. Finally, Piper Sandler initiated coverage on shares of The Cigna Group in a research note on Wednesday. They issued an “overweight” rating and a $400.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $376.20.

Insider Buying and Selling at The Cigna Group

In other news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now owns 2,595 shares of the company’s stock, valued at $904,902.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now directly owns 2,595 shares in the company, valued at approximately $904,902.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 4,795 shares of the business’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the sale, the insider now owns 39,923 shares in the company, valued at approximately $13,773,834.23. The disclosure for this sale can be found here. Insiders have sold a total of 22,988 shares of company stock worth $7,975,726 over the last 90 days. Insiders own 0.60% of the company’s stock.

The Cigna Group Price Performance

Shares of NYSE CI traded down $3.03 during mid-day trading on Thursday, reaching $334.55. The company had a trading volume of 226,040 shares, compared to its average volume of 1,605,853. The Cigna Group has a one year low of $253.95 and a one year high of $365.71. The business’s 50-day simple moving average is $341.96 and its 200 day simple moving average is $332.69. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The firm has a market cap of $95.04 billion, a price-to-earnings ratio of 27.52, a PEG ratio of 1.03 and a beta of 0.53.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share for the quarter, topping analysts’ consensus estimates of $6.17 by $0.30. The company had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The firm’s quarterly revenue was up 23.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.41 EPS. On average, research analysts predict that The Cigna Group will post 28.47 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 20th. Investors of record on Tuesday, June 4th were given a dividend of $1.40 per share. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.67%. The Cigna Group’s dividend payout ratio is currently 45.98%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.